Latest Ratios: P/E Ratio 75.1x · EV/EBITDA 30.0x · ROE 8.2%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $4.2B | $1.9B | $1.9B | $1.7B | $1.0B | $1.2B | $713M | $924M | $1.3B | $1.2B | $1.1B |
| Enterprise Value | $4.7B | $2.4B | $2.0B | $1.7B | $1.1B | $1.3B | $838M | $1.0B | $1.4B | $1.3B | $1.0B |
| P/E Ratio → | 75.10 | 33.72 | 26.25 | 12.23 | 16.75 | 31.85 | 17.39 | 19.56 | 35.73 | 24.85 | 20.30 |
| P/S Ratio | 5.34 | 2.38 | 2.66 | 2.29 | 1.40 | 1.77 | 1.18 | 1.17 | 1.51 | 1.53 | 1.41 |
| P/B Ratio | 5.66 | 2.54 | 3.09 | 2.80 | 2.06 | 2.30 | 1.54 | 1.99 | 2.90 | 2.83 | 2.86 |
| P/FCF | 102.33 | 45.58 | 26.51 | 25.54 | 19.09 | 18.82 | 27.72 | 23.70 | 34.05 | 31.31 | 16.91 |
| P/OCF | 60.66 | 27.02 | 20.70 | 18.71 | 13.22 | 13.92 | 15.09 | 12.60 | 20.13 | 18.25 | 13.15 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 3.01 | 2.71 | 2.31 | 1.55 | 1.93 | 1.39 | 1.30 | 1.60 | 1.67 | 1.37 |
| EV / EBITDA | 30.01 | 15.12 | 15.19 | 8.57 | 9.64 | 13.67 | 9.02 | 9.58 | 12.56 | 14.89 | 11.71 |
| EV / EBIT | 38.73 | 25.66 | 20.52 | 15.09 | 11.37 | 16.16 | 12.51 | 13.23 | 17.71 | 19.26 | 14.26 |
| EV / FCF | — | 57.68 | 26.98 | 25.71 | 21.12 | 20.44 | 32.56 | 26.38 | 36.24 | 34.10 | 16.43 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 38.0% | 38.0% | 39.1% | 38.5% | 36.7% | 36.8% | 35.6% | 33.9% | 34.8% | 33.5% | 33.6% |
| Operating Margin | 15.4% | 15.4% | 14.1% | 23.1% | 12.0% | 9.0% | 10.0% | 9.9% | 9.7% | 8.6% | 9.4% |
| Net Profit Margin | 7.1% | 7.1% | 10.1% | 18.8% | 8.3% | 5.6% | 3.3% | 6.0% | 4.2% | 6.2% | 6.9% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 8.2% | 8.2% | 11.9% | 25.1% | 12.2% | 7.5% | 4.4% | 10.3% | 8.5% | 12.0% | 14.5% |
| ROA | 4.3% | 4.3% | 7.2% | 14.2% | 6.5% | 3.9% | 2.2% | 5.1% | 4.1% | 6.0% | 7.7% |
| ROIC | 9.7% | 9.7% | 12.0% | 20.9% | 10.9% | 7.4% | 7.9% | 10.6% | 12.0% | 11.4% | 15.2% |
| ROCE | 10.7% | 10.7% | 11.6% | 20.5% | 11.0% | 7.3% | 7.6% | 10.2% | 11.5% | 10.3% | 13.1% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.82 | 0.82 | 0.30 | 0.34 | 0.43 | 0.47 | 0.53 | 0.43 | 0.43 | 0.47 | 0.25 |
| Debt / EBITDA | 3.84 | 3.84 | 1.46 | 1.04 | 1.81 | 2.56 | 2.62 | 1.84 | 1.75 | 2.27 | 1.05 |
| Net Debt / Equity | — | 0.67 | 0.05 | 0.02 | 0.22 | 0.20 | 0.27 | 0.22 | 0.19 | 0.25 | -0.08 |
| Net Debt / EBITDA | 3.17 | 3.17 | 0.26 | 0.06 | 0.93 | 1.08 | 1.34 | 0.97 | 0.76 | 1.22 | -0.34 |
| Debt / FCF | — | 12.10 | 0.47 | 0.17 | 2.03 | 1.62 | 4.85 | 2.68 | 2.19 | 2.80 | -0.48 |
| Interest Coverage | 3.88 | 3.88 | 20.93 | 20.98 | 17.03 | 13.05 | 8.96 | 7.22 | 9.78 | 16.20 | 25.07 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.88 | 2.88 | 3.37 | 3.43 | 2.51 | 2.61 | 2.70 | 2.36 | 2.38 | 2.26 | 2.65 |
| Quick Ratio | 2.10 | 2.10 | 2.69 | 2.73 | 1.82 | 1.97 | 2.01 | 1.82 | 1.59 | 1.51 | 1.87 |
| Cash Ratio | 0.63 | 0.63 | 1.21 | 1.39 | 0.70 | 0.95 | 0.97 | 0.66 | 0.68 | 0.55 | 0.91 |
| Asset Turnover | — | 0.50 | 0.72 | 0.72 | 0.79 | 0.68 | 0.65 | 0.86 | 0.95 | 0.87 | 1.09 |
| Inventory Turnover | 3.77 | 3.77 | 5.04 | 4.63 | 4.42 | 4.52 | 4.58 | 6.86 | 4.45 | 4.21 | 4.74 |
| Days Sales Outstanding | — | 107.14 | 84.46 | 76.14 | 73.60 | 76.56 | 69.73 | 52.30 | 50.35 | 62.60 | 51.14 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.4% | 0.8% | 0.7% | 0.8% | 1.2% | 1.0% | 1.5% | 1.1% | 0.7% | 0.7% | 0.6% |
| Payout Ratio | 27.0% | 27.0% | 19.0% | 9.3% | 20.0% | 31.4% | 52.5% | 20.8% | 24.3% | 16.9% | 13.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 1.3% | 3.0% | 3.8% | 8.2% | 6.0% | 3.1% | 5.8% | 5.1% | 2.8% | 4.0% | 4.9% |
| FCF Yield | 1.0% | 2.2% | 3.8% | 3.9% | 5.2% | 5.3% | 3.6% | 4.2% | 2.9% | 3.2% | 5.9% |
| Buyback Yield | 0.2% | 0.5% | 1.7% | 1.5% | 3.1% | 1.8% | 1.5% | 3.6% | 0.2% | 0.7% | 0.5% |
| Total Shareholder Yield | 0.6% | 1.3% | 2.4% | 2.3% | 4.2% | 2.8% | 3.0% | 4.7% | 0.9% | 1.4% | 1.2% |
| Shares Outstanding | — | $12M | $12M | $12M | $12M | $12M | $12M | $13M | $13M | $13M | $13M |
Goodwill impairment risk
According to recent market data, SXI trades at a forward P/E of 39.31 and an EV/EBITDA of 29.90, suggesting that investors are pricing in a significant growth premium as the company transitions from a traditional industrial conglomerate toward a specialized electronics and medical technology provider.
The current valuation multiples appear elevated relative to historical norms, implying that the market is assigning a higher quality of earnings to the Electronics and Scientific segments. This pricing suggests an expectation of sustained margin expansion, though it leaves little room for error should the integration of recent acquisitions fail to deliver the anticipated synergies.
Based on reported financial statements, SXI's ROIC has remained in a narrow range between 1.7% and 3.1% over the last ten quarters, indicating that the rapid accumulation of goodwill from recent acquisitions is currently suppressing the company's overall return on invested capital.
While the underlying business segments demonstrate strong operational margins, the heavy reliance on inorganic growth has inflated the capital base, masking the true economic profitability of the core operations. Investors should monitor whether ROIC can trend upward as the company shifts focus from aggressive acquisition-led expansion to organic margin optimization.
As reported in recent quarterly filings, SXI's cash conversion cycle has fluctuated between 108 and 131 days, reflecting the inherent complexity of managing long-cycle aerospace projects alongside shorter-cycle electronics manufacturing, which continues to tie up significant liquidity in inventory and receivables.
The elevated DSO and DIO figures suggest that the company faces structural challenges in optimizing its working capital, particularly as it integrates new business units with varying operational rhythms. This inefficiency warrants further investigation into whether the current inventory levels are a strategic buffer against supply chain volatility or a sign of operational friction.
The most commonly misapplied metric for SXI is the traditional industrial P/E ratio, which obscures the company's evolving revenue mix by treating it as a cyclical machinery manufacturer rather than a high-margin, specialized technology provider with significant exposure to life sciences and EV infrastructure.
Applying a standard industrial multiple fails to account for the recurring nature of the Engraving segment's design services and the high-barrier-to-entry electronics components. Analysts should instead focus on segment-specific valuation benchmarks or a sum-of-the-parts analysis to better capture the true value of the company's diversified, high-value-add portfolio.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SXI stock.
Standex International Corporation's current P/E ratio is 75.1x. The historical average is 18.7x. This places it at the 100th percentile of its historical range.
Standex International Corporation's current EV/EBITDA is 30.0x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 9.5x.
Standex International Corporation's return on equity (ROE) is 8.2%. The historical average is 12.7%.
Based on historical data, Standex International Corporation is trading at a P/E of 75.1x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Standex International Corporation's current dividend yield is 0.36% with a payout ratio of 27.0%.
Standex International Corporation has 38.0% gross margin and 15.4% operating margin. Operating margin between 10-20% is typical for established companies.
Standex International Corporation's Debt/EBITDA ratio is 3.8x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.